# Phase II Trial of Pulsed Taxol With Concurrent Thoracic Radiotherapy, & Adjuvant Chemo in Stage III NSCLC

> **NCT00449657** · PHASE2 · TERMINATED · sponsor: **Leo W. Jenkins Cancer Center** · enrollment: 24 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DRUG:** Taxol (paclitaxel)
- **PROCEDURE:** Radiotherapy
- **DRUG:** Carboplatin
- **DRUG:** Gemcitabine

## Key facts

- **NCT ID:** NCT00449657
- **Lead sponsor:** Leo W. Jenkins Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-02
- **Primary completion:** 2017-08-22
- **Final completion:** 2017-08-22
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** Poor accrual, change in standard of care.
- **Last updated:** 2018-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00449657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00449657, "Phase II Trial of Pulsed Taxol With Concurrent Thoracic Radiotherapy, & Adjuvant Chemo in Stage III NSCLC". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00449657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*